Menu

Recent Interviews

Stephan Dorfmeister, Finance Department, Deep Nature Project GmbH

Stephan Dorfmeister
Finance Department | Deep Nature Project GmbH
Untere Hauptstraße 168, 7122 Gols (AT)

office@deep-nature.at

+43 681 10139055

Like Aurora Cannabis and Canopy Growth, Deep Nature Project GmbH focuses on value chain


Alison Coutts, Executive Chairman, Memphasys Ltd.

Alison Coutts
Executive Chairman | Memphasys Ltd.
30 Richmond Road, 2140 Homebush West (AUS)

alison.coutts@memphasys.com

+61 2 8415 7300

Memphasys Executive Chairman Alison Coutts on in vitro fertilisation (IVF)


Thomas Soltau, CEO, wallstreet:online capital AG

Thomas Soltau
CEO | wallstreet:online capital AG
Michaelkirchstraße 17/18, 10179 Berlin (D)

service@smartbroker.de

+49 30 27 57 76 464

Smartbroker - wallstreet:online capital AG CEO Thomas Soltau in an interview on the market launch


27. March 2020 | 14:20 CET

Drägerwerk or Micro-X - how do investors benefit from the Corona Pandemic?

  • Healthcare

The current Corona Pandemic is challenging people around the globe. Doctors and medical staff are under particular strain. For some time now, it has become clear that there is a lack of material and equipment to withstand a large onslaught of infected Covid-19 patients. In order to slow down the spread of the virus, the population is urged to avoid social contacts. Manufacturers of equipment and materials for the medical sector are now being flooded with orders to compensate for the shortage, and investors have the opportunity to make a financial investment.

time to read: 1 minutes by Mario Hose


 

Federal government fills supply gap

The ventilators and medical protective equipment of Drägerwerk AG & Co. KGaA are in great demand. Two weeks ago, the company received a major order from the German government. According to the announcement, the delivery of 10,000 ventilators and protective equipment for medical personnel was agreed. The delivery will cover the next 12 months. This order is directly related to the spread of the corona virus and will be used to supply the healthcare system.

Product to combat shortages

In addition to ventilators, X-ray equipment is also needed to monitor the course of the disease in the patient's lungs. In recent years, the Australian company Micro-X Limited has developed a mobile X-ray unit that is now going into series production. The device is called the Carestream DRX Revolution Nano. The advantage is that the device can be moved, which increases the treatment comfort of the patients.

Based on the demand for the devices, the company will adapt its growth strategy and immediately initiate operational measures originally planned for a later date, Micro-X recently announced. As hospitals are now the focus of events and gaps in medical care are becoming apparent, more money is expected to flow into healthcare now and in the future.

Sales increase significantly

While Drägerwerk is a traditional billion-dollar company, at Micro-X investors can enter a growth story that is now experiencing high demand. In the past fiscal year, the company generated sales of AUD 1.9 million and was already able to announce incoming orders of AUD 2.4 million in the first quarter of 2020.

Micro-X's market capitalisation is currently AUD 31.25 million at the closing price of AUD 0.125 on the home exchange ASX. The shares of the company are not (yet) listed in Germany but information on the security is available and trading on the ASX is possible via the following details: ISIN: AU0000MX15, WKN: A2ACCY, ASX: MX1 or via the website: micro-x.com.


Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold shares in the aforementioned companies and that there may therefore be a conflict of interest. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

26. May 2020 | 07:43 CET

BioNTech, Evotec, XPhyto - will the next rally start?

  • Healthcare

Germany's leading index DAX closed the previous day at 11,391 points, its highest level since March 2020. At the beginning of the week the index of the 30 largest German companies gained 317 points compared to Friday, representing a gain of 2.87%. In the USA Wall Street remained closed on Monday due to the Memorial Day. As is well known, the stock market is where the future is traded and for this reason investors are already investing in the prospects of companies in the period following the Corona Pandemic. A rally has begun.

Read

20. April 2020 | 09:43 CET

Bayer, EXMceuticals, Symrise - investing in the healthcare growth market

  • Healthcare

The Corona Pandemic brings with it many changes. The influences in the supply chain are affecting the economy to the point of stagnation. The lack of contact for people creates challenges in coping with everyday life. The term 'home office' is used in an inflationary way - and often misused, because the difference between 'home office' and 'working from home' is the noise and stress level around it. On top of this, there are also supply bottlenecks for hygiene products, basic foodstuffs and protective equipment. According to a recent statement by the Federal Minister of Economics, Peter Altmaier (CDU), Germany will need 12 billion masks per year to protect the population. But the well-being of the people also depends on other factors.

Read